FPR2 and early-onset autosomal dominant Alzheimer disease: Additionally, mouse models of Alzheimer’s disease have shown that norepinephrine induces expression of formyl peptide receptor 2 (ALX/FPR2) [16], which is one of two known receptors for RvD1 [17, 18].